Otilimab is a human monoclonal antibody directed against the granulocyte-macrophage colony stimulating factor (GM-CSF). Otilimab has been used in the research of moderate to severe rheumatoid arthritis.
BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.